Published in J Neurotrauma on January 01, 2009
Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br J Pharmacol (2011) 1.28
NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J Neuroinflammation (2009) 0.87
Correlations between blood-brain barrier disruption and neuroinflammation in an experimental model of penetrating ballistic-like brain injury. J Neurotrauma (2014) 0.86
A military-centered approach to neuroprotection for traumatic brain injury. Front Neurol (2013) 0.81
Comprehensive Evaluation of Neuroprotection Achieved by Extended Selective Brain Cooling Therapy in a Rat Model of Penetrating Ballistic-Like Brain Injury. Ther Hypothermia Temp Manag (2015) 0.81
Enhancement of neurogenesis and memory by a neurotrophic peptide in mild to moderate traumatic brain injury. Neurosurgery (2015) 0.81
Combination Therapies for Traumatic Brain Injury: Retrospective Considerations. J Neurotrauma (2015) 0.80
Pathophysiological links between traumatic brain injury and post-traumatic headaches. F1000Res (2016) 0.75
Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord (2017) 0.75
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell (2010) 3.25
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care (2011) 1.68
Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med (2011) 1.65
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci U S A (2003) 1.62
Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord (2002) 1.41
Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg (2012) 1.34
Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection. J Neurosci (2003) 1.31
Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma (2011) 1.31
Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab (2002) 1.29
Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci (2010) 1.28
Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics (2006) 1.28
Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res (2004) 1.20
Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2004) 1.18
Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J (2006) 1.18
Proteomic identification of biomarkers of traumatic brain injury. Expert Rev Proteomics (2005) 1.14
IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer. Am J Surg Pathol (2011) 1.13
Characterization of a new rat model of penetrating ballistic brain injury. J Neurotrauma (2005) 1.11
Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. J Pharmacol Exp Ther (2006) 1.09
Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration. J Neurotrauma (2006) 1.09
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration. J Cereb Blood Flow Metab (2003) 1.08
Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. J Neuroinflammation (2007) 1.08
Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury. J Neurochem (2006) 1.07
Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia. Exp Neurol (2003) 1.07
Spreading depolarizations and late secondary insults after traumatic brain injury. J Neurotrauma (2009) 1.06
Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem Int (2006) 1.03
Serum brain biomarker level, neurocognitive performance, and self-reported symptom changes in soldiers repeatedly exposed to low-level blast: a breacher pilot study. J Neurotrauma (2013) 1.01
Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat. Brain Res (2002) 0.97
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke (2004) 0.97
Interactions that determine the assembly of a retinoid X receptor/corepressor complex. Proc Natl Acad Sci U S A (2002) 0.97
Severity level and injury track determine outcome following a penetrating ballistic-like brain injury in the rat. Neurosci Lett (2006) 0.95
Repetitive cortical spreading depolarizations in a case of severe brain trauma. Neurol Res (2008) 0.94
CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice. J Clin Immunol (2012) 0.94
Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation. Neurosci Lett (2007) 0.93
Longitudinal characterization of motor and cognitive deficits in a model of penetrating ballistic-like brain injury. J Neurotrauma (2010) 0.90
A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy. J Trauma (2011) 0.89
Cholinergic mechanism involved in the nociceptive modulation of dentate gyrus. Biochem Biophys Res Commun (2009) 0.89
Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia. Neuroreport (2002) 0.89
Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4. Mol Cell Biol (2013) 0.89
NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J Neuroinflammation (2009) 0.87
Severity profile of penetrating ballistic-like brain injury on neurofunctional outcome, blood-brain barrier permeability, and brain edema formation. J Neurotrauma (2011) 0.87
Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis. Eur J Pharmacol (2002) 0.87
Electrocortical pathology in a rat model of penetrating ballistic-like brain injury. J Neurotrauma (2010) 0.86
A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia. Proc Natl Acad Sci U S A (2006) 0.86
Correlations between blood-brain barrier disruption and neuroinflammation in an experimental model of penetrating ballistic-like brain injury. J Neurotrauma (2014) 0.86
Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats. Brain Inj (2008) 0.85
Human amnion-derived multipotent progenitor cell treatment alleviates traumatic brain injury-induced axonal degeneration. J Neurotrauma (2009) 0.85
P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury. J Neurotrauma (2009) 0.85
Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury. J Neurotrauma (2013) 0.85
A metabolic profiling analysis of symptomatic gout in human serum and urine using high performance liquid chromatography-diode array detector technique. Clin Chim Acta (2011) 0.84
AC electrocorticographic correlates of peri-infarct depolarizations during transient focal ischemia and reperfusion. J Cereb Blood Flow Metab (2006) 0.84
The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage. Med Res Rev (2013) 0.84
Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury. J Neurotrauma (2010) 0.84
The diagnosis of traumatic brain injury on the battlefield. Front Neurol (2012) 0.83
Similarities and differences of acute nonconvulsive seizures and other epileptic activities following penetrating and ischemic brain injuries in rats. J Neurotrauma (2013) 0.83
A military-centered approach to neuroprotection for traumatic brain injury. Front Neurol (2013) 0.81
Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury. Electrophoresis (2012) 0.81
Regulation of the behaviors of mesenchymal stem cells by surface nanostructured titanium. Colloids Surf B Biointerfaces (2012) 0.81
A comparison of two cognitive test paradigms in a penetrating brain injury model. J Neurosci Methods (2010) 0.81
Selective brain cooling in rats ameliorates intracerebral hemorrhage and edema caused by penetrating brain injury: possible involvement of heme oxygenase-1 expression. J Neurotrauma (2011) 0.81
Influence of phosphate anion adsorption on the kinetics of oxygen electroreduction on low index Pt(hkl) single crystals. Phys Chem Chem Phys (2010) 0.81
Molybdenum carbide as alternative catalysts to precious metals for highly selective reduction of CO2 to CO. Angew Chem Int Ed Engl (2014) 0.80
Brain oxygen tension monitoring following penetrating ballistic-like brain injury in rats. J Neurosci Methods (2011) 0.80